Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis NJ Welton, A McAleenan, HHZ Thom, P Davies, W Hollingworth, ... Health technology assessment 21 (29), 2017 | 164 | 2017 |
The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial Lancet Psychiatry, 2019 | 109 | 2019 |
Choice of implant combinations in total hip replacement: systematic review and network meta-analysis JA López-López, RL Humphriss, AD Beswick, HHZ Thom, LP Hunt, ... bmj 359, 2017 | 99 | 2017 |
At what price? A cost-effectiveness analysis comparing trial of labour after previous caesarean versus elective repeat caesarean delivery CG Fawsitt, J Bourke, RA Greene, CM Everard, A Murphy, JE Lutomski PLoS One 8 (3), e58577, 2013 | 83 | 2013 |
Choice of prosthetic implant combinations in total hip replacement: cost-effectiveness analysis using UK and Swedish hip joint registries data CG Fawsitt, HHZ Thom, LP Hunt, S Nemes, AW Blom, NJ Welton, ... Value in Health 22 (3), 303-312, 2019 | 45 | 2019 |
What women want: exploring pregnant women’s preferences for alternative models of maternity care CG Fawsitt, J Bourke, JE Lutomski, S Meaney, B McElroy, R Murphy, ... Health policy 121 (1), 66-74, 2017 | 41 | 2017 |
Effectiveness of public health measures to prevent the transmission of SARS‐CoV‐2 at mass gatherings: a rapid review KA Walsh, B Tyner, N Broderick, P Harrington, M O’Neill, CG Fawsitt, ... Reviews in Medical Virology 32 (3), e2285, 2022 | 25 | 2022 |
What do women want? Valuing women’s preferences and estimating demand for alternative models of maternity care using a discrete choice experiment CG Fawsitt, J Bourke, RA Greene, B McElroy, N Krucien, R Murphy, ... Health Policy 121 (11), 1154-1160, 2017 | 23 | 2017 |
A cost-effectiveness analysis of shortened direct-acting antiviral treatment in genotype 1 noncirrhotic treatment-naive patients with chronic hepatitis C virus CG Fawsitt, P Vickerman, G Cooke, NJ Welton, E Barnes, J Ball, ... Value in Health 22 (6), 693-703, 2019 | 13 | 2019 |
Cost-effectiveness of metabolic surgery for the treatment of type 2 diabetes and obesity: a systematic review of economic evaluations K Jordan, CG Fawsitt, PG Carty, B Clyne, C Teljeur, P Harrington, M Ryan The European Journal of Health Economics 24 (4), 575-590, 2023 | 12 | 2023 |
A cost-benefit analysis of two alternative models of maternity care in Ireland CG Fawsitt, J Bourke, A Murphy, B McElroy, JE Lutomski, R Murphy, ... Applied health economics and health policy 15, 785-794, 2017 | 12 | 2017 |
Antidepressant treatment with sertraline for adults with depressive symptoms in primary care: the PANDA research programme including RCT | 10* | |
Effectiveness of rapid antigen testing for screening of asymptomatic individuals to limit the transmission of SARS‐CoV‐2: A rapid review KA Walsh, N Broderick, S Ahern, CG Fawsitt, KM O’Brien, M Carrigan, ... Reviews in Medical Virology 32 (5), e2350, 2022 | 9 | 2022 |
A cost-effectiveness and budget impact analysis of C-reactive protein point-of-care testing to guide antibiotic prescribing for acute respiratory tract infections in primary … CG Fawsitt, D Lucey, P Harrington, K Jordan, L Marshall, KK O’Brien, ... Family Practice 39 (3), 389-397, 2022 | 8 | 2022 |
Surgical site infection after caesarean section? There is an app for that: results from a feasibility study on costs and benefits CG Fawsitt, S Meaney, RA Greene, P Corcoran Irish Medical Organisation, 2017 | 6 | 2017 |
Population-based testing for undiagnosed hepatitis C: a systematic review of economic evaluations PG Carty, CG Fawsitt, P Gillespie, P Harrington, M O’Neill, SM Smith, ... Applied health economics and health policy 20 (2), 171-183, 2022 | 4 | 2022 |
Comparison of indirect treatment methods in migraine prevention to address differences in mode of administration CG Fawsitt, H Thom, SA Regnier, XY Lee, S Kymes, L Vase Journal of Comparative Effectiveness Research 12 (7), e230021, 2023 | 3 | 2023 |
Cost-effectiveness of sertraline in primary care according to initial severity and duration of depressive symptoms: findings from the PANDA RCT W Hollingworth, CG Fawsitt, P Dixon, L Duffy, R Araya, TJ Peters, H Thom, ... PharmacoEconomics-Open 4, 427-438, 2020 | 3 | 2020 |
POSC124 economic burden of antimicrobial resistance: an analysis of the additional bed day costs associated with treating resistant infections in ireland N Broderick, KA Walsh, KK O'Brien, SS Smith, P Harrington, M O'Neill, ... Value in Health 25 (1), S111, 2022 | 2 | 2022 |
PMD18 a cost-effectiveness and budget impact analysis of C-reactive protein point-of-care testing to guide antibiotic prescribing for respiratory tract infections in primary … CG Fawsitt, D Lucey, P Harrington, K Jordan, L Marshall, KK O'Brien, ... Value in Health 22, S672, 2019 | 2 | 2019 |